Slide One - Equine
Global Excellence

in Animal Pharmaceuticals

Slide Two - Cattle
Global Excellence

in Animal Pharmaceuticals

Slide Three- Equine
Global Excellence

in Animal Pharmaceuticals

Slide Seven- Swine
Global Excellence

in Animal Pharmaceuticals

Slide Five- Equine
Global Excellence

in Animal Pharmaceuticals

Slide Six - Poultry
Global Excellence

in Animal Pharmaceuticals

Slide Four - Manufacturing
Global Excellence

in Manufacturing & Distribution

previous arrow
next arrow

Global Excellence in Animal Health

Woodfield Corporate CenterWelcome to the Bimeda® US website. Bimeda® is a leading global manufacturer, marketer and distributor of animal health products and veterinary pharmaceuticals.

Bimeda® US headquarters are based in Schaumburg, Illinois. The Bimeda® US product portfolio focuses on five key categories: ecto- and endo-parasiticides, water soluble antimicrobials, injectables and nutritional products. Bimeda® is focused on providing a comprehensive, customer-driven service and selling consistently high-quality products at a market-conscious price level.

Through ongoing expansion and strategic acquisition, Bimeda® has established markets in more than eighty countries worldwide and has R&D, manufacturing and distribution capabilities across Europe, North America, South America, Africa, Asia and Australia. Bimeda® employs over employees worldwide and has its global headquarters in Dublin, Ireland.

gada logoBimeda® is a proud member of the GADA (Generic Animal Drug Alliance). GADA is an independent, professional trade association that represents the interests of generic animal drug companies. GADA supports the education of veterinarians and the general public on the topic of generic drugs safety, quality process and FDA approval. With the support of GADA, generic animal drug companies like Bimeda® ensure that veterinarian and animal owners have access to safe and effective generic drugs.

To learn more about Bimeda’s global presence, why not read our corporate brochure.

Latest News

13 November 2024
Schaumburg, Illinois – Bimeda is excited to announce the expansion of its anti-parasitic portfolio with the introduction of MoxiSolv Injection (moxidectin). MoxiSolv stands out as the only FDA-approved, bioequivalent alternative to Cydectin® Injectab...
04 September 2024
Bimeda is pleased to announce the appointment of Colby Flatt as Senior Territory Manager for the region of Southern Missouri, Eastern Oklahoma and Arkansas. Colby will be an integral part of the US Cattle Sales team. Colby brings years of experience ...
22 July 2024
Bimeda is pleased to announce the appointment of Casey Story as Senior Territory Manager. Casey will be an integral part of US Cattle Sales team in the states of Kentucky, Tennessee, Mississippi, Alabama, South Carolina, Virginia, West Virginia and G...